Campaign for CME

As I Read the op-ed piece “Does a Drug Firm's Free Lunch Influence Doctors?” (Boston Globe, May 18), I thought, how unusual — this writer actually seems to have a positive attitude about pharmaceutical industry/physician relationships. The piece was responding to the survey of those interactions published recently in The New England Journal of Medicine. Then I saw the byline — Scott Lassman, senior assistant general counsel for the Pharmaceutical Research and Manufacturers of